Darya-Varia Laboratoria Tbk (DVLA) - Total Assets
Based on the latest financial reports, Darya-Varia Laboratoria Tbk (DVLA) holds total assets worth Rp2.40 Trillion IDR (≈ $140.52 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See DVLA net asset value for net asset value and shareholders' equity analysis.
Darya-Varia Laboratoria Tbk - Total Assets Trend (2000–2024)
This chart illustrates how Darya-Varia Laboratoria Tbk's total assets have evolved over time, based on quarterly financial data.
Darya-Varia Laboratoria Tbk - Asset Composition Analysis
Current Asset Composition (December 2024)
Darya-Varia Laboratoria Tbk's total assets of Rp2.40 Trillion consist of 70.4% current assets and 29.6% non-current assets.
| Asset Category | Amount (IDR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 16.6% |
| Accounts Receivable | Rp741.93 Billion | 34.3% |
| Inventory | Rp398.56 Billion | 18.4% |
| Property, Plant & Equipment | Rp472.88 Billion | 21.9% |
| Intangible Assets | Rp57.21 Billion | 2.7% |
| Goodwill | Rp10.28 Billion | 0.5% |
Asset Composition Trend (2000–2024)
This chart illustrates how Darya-Varia Laboratoria Tbk's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Darya-Varia Laboratoria Tbk.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Darya-Varia Laboratoria Tbk's current assets represent 70.4% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 16.6% of total assets in 2024, up from 3.8% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 28.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 34.3% of total assets.
Darya-Varia Laboratoria Tbk Competitors by Total Assets
Key competitors of Darya-Varia Laboratoria Tbk based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.34 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥15.32 Billion |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
China | CN¥10.96 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
Darya-Varia Laboratoria Tbk - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.37 | 2.57 | 3.25 |
| Quick Ratio | 1.75 | 1.93 | 2.27 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rp1.01 Trillion | Rp984.12 Billion | Rp944.57 Billion |
Darya-Varia Laboratoria Tbk - Advanced Valuation Insights
This section examines the relationship between Darya-Varia Laboratoria Tbk's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.21 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 5.8% |
| Total Assets | Rp2.16 Trillion |
| Market Capitalization | $105.33 Million USD |
Valuation Analysis
Below Book Valuation: The market values Darya-Varia Laboratoria Tbk's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Darya-Varia Laboratoria Tbk's assets grew by 5.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Darya-Varia Laboratoria Tbk (2000–2024)
The table below shows the annual total assets of Darya-Varia Laboratoria Tbk from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Rp2.16 Trillion ≈ $126.66 Million |
+5.85% |
| 2023-12-31 | Rp2.04 Trillion ≈ $119.66 Million |
+1.64% |
| 2022-12-31 | Rp2.01 Trillion ≈ $117.73 Million |
-3.68% |
| 2021-12-31 | Rp2.09 Trillion ≈ $122.23 Million |
+4.99% |
| 2020-12-31 | Rp1.99 Trillion ≈ $116.41 Million |
+8.57% |
| 2019-12-31 | Rp1.83 Trillion ≈ $107.23 Million |
+8.74% |
| 2018-12-31 | Rp1.68 Trillion ≈ $98.61 Million |
+2.56% |
| 2017-12-31 | Rp1.64 Trillion ≈ $96.15 Million |
+7.15% |
| 2016-12-31 | Rp1.53 Trillion ≈ $89.73 Million |
+11.27% |
| 2015-12-31 | Rp1.38 Trillion ≈ $80.64 Million |
+11.33% |
| 2014-12-31 | Rp1.24 Trillion ≈ $72.44 Million |
+3.88% |
| 2013-12-31 | Rp1.19 Trillion ≈ $69.73 Million |
+10.73% |
| 2012-12-31 | Rp1.07 Trillion ≈ $62.97 Million |
+15.77% |
| 2011-12-31 | Rp928.29 Billion ≈ $54.39 Million |
+8.69% |
| 2010-12-31 | Rp854.11 Billion ≈ $50.05 Million |
+9.00% |
| 2009-12-31 | Rp783.61 Billion ≈ $45.92 Million |
+22.89% |
| 2008-12-31 | Rp637.66 Billion ≈ $37.36 Million |
+13.68% |
| 2007-12-31 | Rp560.93 Billion ≈ $32.87 Million |
+0.64% |
| 2006-12-31 | Rp557.34 Billion ≈ $32.66 Million |
+1.22% |
| 2005-12-31 | Rp550.63 Billion ≈ $32.26 Million |
+27.70% |
| 2004-12-31 | Rp431.17 Billion ≈ $25.27 Million |
+15.42% |
| 2003-12-31 | Rp373.56 Billion ≈ $21.89 Million |
+15.68% |
| 2002-12-31 | Rp322.92 Billion ≈ $18.92 Million |
-15.12% |
| 2001-12-31 | Rp380.44 Billion ≈ $22.29 Million |
+1.11% |
| 2000-12-31 | Rp376.28 Billion ≈ $22.05 Million |
-- |
About Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women hea… Read more